BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18521928)

  • 1. Urinary neopterin is a valuable tool in monitoring Crohn's disease activity.
    Nancey S; Perret-Liaudet A; Moussata D; Graber I; Boschetti G; Renaud B; Kaiserlian D; Reimund JM; Flourié B
    Inflamm Bowel Dis; 2008 Nov; 14(11):1548-54. PubMed ID: 18521928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
    Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A level correlated with endoscopic findings in patients with Crohn's disease-Possible biomarker for evaluating mucosal healing.
    Ishihara S; Tada Y; Kawashima K; Kataoka M; Sonoyama H; Yamashita N; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kinoshita Y
    Dig Liver Dis; 2018 Jun; 50(6):553-558. PubMed ID: 29311027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
    Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple index relating clinical activity in Crohn's disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters.
    Reibnegger G; Bollbach R; Fuchs D; Hausen A; Judmaier G; Prior C; Rotthauwe HW; Werner ER; Wachter H
    Immunobiology; 1986 Oct; 173(1):1-11. PubMed ID: 3492436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated urinary orosomucoid excretion as a novel biomarker in Crohn's disease.
    Szirmay B; Tárnok A; Sarlós P; Szigeti N; Ludány A; Kustán P; Horváth-Szalai Z; Miseta A; Kőszegi T
    Eur J Clin Invest; 2019 Mar; 49(3):e13054. PubMed ID: 30451301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neopterin, a marker of clinical activity in patients with Crohn's disease.
    Prior C; Bollbach R; Fuchs D; Hausen A; Judmaier G; Niederwieser D; Reibnegger G; Rotthauwe HW; Werner ER; Wachter H
    Clin Chim Acta; 1986 Feb; 155(1):11-21. PubMed ID: 3698305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.
    Sipponen T; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2008 Jan; 14(1):40-6. PubMed ID: 18022866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Crohn's disease is associated with low vitamin D levels.
    Jørgensen SP; Hvas CL; Agnholt J; Christensen LA; Heickendorff L; Dahlerup JF
    J Crohns Colitis; 2013 Nov; 7(10):e407-13. PubMed ID: 23403039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Albumin and C-Reactive Protein/Albumin Ratio Are Useful Biomarkers of Crohn's Disease Activity.
    Qin G; Tu J; Liu L; Luo L; Wu J; Tao L; Zhang C; Geng X; Chen X; Ai X; Shen B; Pan W
    Med Sci Monit; 2016 Nov; 22():4393-4400. PubMed ID: 27848931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
    Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
    J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
    Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
    Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and monitoring the activity of Crohn's disease.
    Filik L; Dagli U; Ulker A
    Adv Ther; 2006; 23(4):655-62. PubMed ID: 17050508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
    Chamouard P; Richert Z; Meyer N; Rahmi G; Baumann R
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):882-7. PubMed ID: 16630759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.